Pharmacokinetics and Pharmacodynamics in Cardiology

Understanding the pharmacokinetics (PK) and pharmacodynamics (PD) of cardiovascular drugs is essential for optimizing treatment outcomes in cardiology. This session will delve into how the absorption, distribution, metabolism, and excretion (ADME) of cardiovascular medications influence their efficacy and safety. Topics will include the impact of age, genetics, and comorbidities on drug metabolism, as well as how PK/PD modeling can inform drug dosing, especially in patients with heart failure, arrhythmias, and hypertension. Additionally, we will explore the clinical application of therapeutic drug monitoring, the role of biomarkers, and advancements in personalized dosing strategies to improve patient care in cardiovascular medicine.

    Related Conference of Pharmacokinetics and Pharmacodynamics in Cardiology

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Pharmacokinetics and Pharmacodynamics in Cardiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in